Arjun Agarwal
Net worth: 1 M $ as of 2026-07-30
Net worth: 1 M $ as of 2026-07-30
Arjun Agarwal currently works at Oruka Therapeutics, Inc., as Treasurer & Senior Vice President-Finance from 2024.
Mr. Agarwal also formerly worked at McKesson Corp., as Senior Director-FP&A, Protagonist Therapeutics, Inc., as VP-Finance & Corporate Controller from 2019 to 2021, and Jasper Therapeutics, Inc., as Vice President-Finance & Controller from 2021 to 2024.
Mr. Agarwal received his undergraduate degree from Sydenham College of Commerce & Economics.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
0.03% | 2026-08-12 | 15,312 ( 0.03% ) | 1 M $ | 2026-07-30 |
| Companies | Position | Start |
|---|
| Companies | Position | End |
|---|---|---|
| JASPER THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 2024-02-29 |
| PROTAGONIST THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 2021-05-31 |
| MCKESSON CORPORATION | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
McKesson Corp.
McKesson Corp. Medical DistributorsDistribution Services Distributes pharmaceuticals and medical supplies & provides related technology services | Distribution Services |
Sydenham College of Commerce & Economics
Sydenham College of Commerce & Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protagonist Therapeutics, Inc.
Protagonist Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures peptide based therapeutic products | Health Technology |
Jasper Therapeutics, Inc.
Jasper Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company which engages in enabling cures through hematopoietic stem cell therapy | Health Technology |
Select your edition
All financial news and data tailored to specific country editions